Too Long; Didn't Read

Ivan Drokin discusses the significant impact of AI in biotech and medtech, emphasizing its role in drug discovery, disease diagnostics, and healthcare optimization. He highlights the challenges of sourcing data and navigating regulations but remains optimistic about AI's potential to advance medicine globally. Drokin shares insights from his career transitions, "wow" moments in AI research, and his contributions to AI applications in various domains. He also addresses the ethical and regulatory dimensions of AI development and envisions critical areas where AI will soon make significant strides in biotechnology.

journalist, tech entrepreneur